NeuroPace (NPCE) Share-based Compensation (2020 - 2026)
NeuroPace (NPCE) posted quarterly Share-based Compensation of $176000.0 for Q1 2026, down 93.3% year-over-year from $2.6 million in Q1 2025, and up 100.0% quarter-over-quarter from $88000.0 in Q4 2025.
NeuroPace (NPCE) Share-based Compensation (2020 - 2026) Analysis & Trends
NeuroPace's Share-based Compensation history runs 7 years deep, the most recent figure standing at $176000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 93.3% year-over-year to $176000.0; the TTM figure through Mar 2026 stood at -$1.9 million (down 166.72% YoY), while the FY2025 annual figure was $543000.0, down 38.37% from the prior year.
- Share-based Compensation for Q1 2026 stood at $176000.0, up from $88000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $10.5 million in Q3 2022, with the low at -$6.9 million in Q4 2023.
- The 5-year median for Share-based Compensation is $176000.0 (2026), against an average of $600470.6.
- Peak annual rise in Share-based Compensation reached 636.63% in 2022, while the deepest fall reached 613.37% in 2022.
- NeuroPace's Share-based Compensation stood at -$2.2 million in 2022, then tumbled by 210.47% to -$6.9 million in 2023, then advanced by 2.07% to -$6.8 million in 2024, then soared by 101.29% to $88000.0 in 2025, then surged by 100.0% to $176000.0 in 2026.
- Business Quant data shows NPCE's Share-based Compensation at $176000.0 in Q1 2026, $88000.0 in Q4 2025, and $53000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | 176,000.00 |
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | -2.22 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | -6.80 Mn |
| Dec 31, 2024 | -6.80 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 649,000.00 |
| Mar 31, 2024 | 649,000.00 |